Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia
Affiliations
Affiliations
- Department of Child and Adolescent Psychiatry , Kuwait Centre for Mental Health , Kuwait ;
- Neuromodulation Unit, Department of General Adult Psychiatry , Kuwait Centre for Mental Health , Kuwait.
Abstract
We report a case of early onset schizophrenia that responded favourably to paliperidone but experienced hyperprolactinaemia, tremors, and weight gain, with impaired fasting glycaemia. Addition of bromocriptine helped with both hyperprolactinaemia and tremors, but also brought about euglycaemia and, strikingly, ameliorated negative symptoms.
Keywords: Bromocriptine; Hyperprolactinaemia; Metabolic syndrome; Negative domain; Paliperidone; Schizophrenia..
Similar articles
Petrić D, Rački V, Gačo N, Kaštelan A, Graovac M.J Child Adolesc Psychopharmacol. 2019 Apr;29(3):197-204. doi: 10.1089/cap.2018.0044. Epub 2019 Feb 13.PMID: 30758986
Ahmed N.Isr J Psychiatry. 2017 Dec 1;54(2):59-60.PMID: 29644812 No abstract available.
Qiao Y, Yang F, Li C, Guo Q, Wen H, Zhu S, Ouyang Q, Shen W, Sheng J.Psychiatry Res. 2016 Mar 30;237:83-9. doi: 10.1016/j.psychres.2015.12.033. Epub 2015 Dec 28.PMID: 26921057
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
Jarema M, Bieńkowski P, Heitzman J, Parnowski T, Rybakowski J.Psychiatr Pol. 2017 Feb 26;51(1):7-21. doi: 10.12740/PP/64581. Epub 2017 Feb 26.PMID: 28455891 Review. English, Polish.
Mauri MC, Reggiori A, Paletta S, Di Pace C, Altamura AC.Expert Opin Drug Saf. 2017 Mar;16(3):365-379. doi: 10.1080/14740338.2017.1288716. Epub 2017 Feb 9.PMID: 28140680 Review.
Cited by
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.
Aslanoglou D, Bertera S, Friggeri L, Sánchez-Soto M, Lee J, Xue X, Logan RW, Lane JR, Yechoor VK, McCormick PJ, Meiler J, Free RB, Sibley DR, Bottino R, Freyberg Z.iScience. 2022 Jul 19;25(8):104771. doi: 10.1016/j.isci.2022.104771. eCollection 2022 Aug 19.PMID: 35982797 Free PMC article.
Naguy A.Indian J Psychol Med. 2018 May-Jun;40(3):299-300. doi: 10.4103/IJPSYM.IJPSYM_47_18.PMID: 29875544 Free PMC article. No abstract available.
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.
Freyberg Z, Aslanoglou D, Shah R, Ballon JS.Front Neurosci. 2017 Jul 28;11:432. doi: 10.3389/fnins.2017.00432. eCollection 2017.PMID: 28804444 Free PMC article.